-
The Week Ahead In Biotech: JPMorgan Healthcare Conference, FDA Panel Reviews Opioid Pain Drugs, I-Mab's IPO
Sunday, January 12, 2020 - 6:05pm | 548Read More...Activity in the biotech space is likely to pick up this week. Events are likely to be headlined by the annual JPMorgan Healthcare Conference. Biotech stocks closed 2019 with gains, although they underperformed relative to the broader market. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
-
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Friday, January 10, 2020 - 9:52am | 709Read More...The 38th annual JPMorgan Healthcare Conference, which is tipped off as the biggest health care investment symposium, kicks off Monday in San Francisco, California. From the high and mighty to the smallest of nanocaps, biopharma and health care companies have scheduled presentations at the four-day...
-
Syndax's CEO Presents 3 Immediate Objectives, Possible Partnerships, Drug Pricing And More
Friday, January 20, 2017 - 12:41pm | 862Read More...Syndax Pharmaceuticals Inc (NASDAQ: SNDX) is a clinical stage bio-pharmaceutical company that focuses on development of therapies in multiple cancer indications. Benzinga had the opportunity to chat with Briggs Morrison, M.D., Syndax's CEO and director. The interview took place at a time when the...
-
Egalet's FDA Approval May Have Triggered Major Short Squeeze
Monday, January 9, 2017 - 3:10pm | 271Read More...Egalet Corp (NASDAQ: EGLT) shares jumped as much as 17 percent on Monday before being halted following news that the FDA has approved ARYMO ER. In its JPMorgan Healthcare Conference presentation, the company said it plans to launch ARYMO ER starting in Q1 2017. The positive news and subsequent halt...
-
Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation
Monday, January 9, 2017 - 12:40pm | 636Read More...Benzinga recently had the chance to speak with ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) CEO Dr. Laurence James Neil Cooper about the upcoming JPMorgan Healthcare Conference, partnerships with Intrexon Corp (NYSE: XON) and Merck & Co., Inc. (NYSE: MRK) and whether shareholders should be concerned...
-
Abiomed Ticks Higher Following Q3 Guidance
Tuesday, January 12, 2016 - 9:11am | 130Read More...Shares of ABIOMED, Inc. (NASDAQ: ABMD) were trading higher by nearly 2 percent early Tuesday morning after the company announced preliminary third quarter results. Abiomed said that its preliminary third quarter fiscal 2016 revenue rose 38 percent from a year ago to approximately $85.8 million...
-
Alere Drops After Trading Halt, JPMorgan Presentation; Recovers To Session Highs
Monday, January 11, 2016 - 1:15pm | 129Read More...Shares of Alere Inc (NYSE: ALR) were halted shortly after 10:15 AM EST on Monday ahead of the company's presentation at the JPMorgan Healthcare Conference. During Alere's presentation, the company's CEO, Namal Nawana, issued fourth quarter guidance. The company noted "unplanned...
-
Shares Of Celgene Plunge Following Busy Slate Of Announcements At JPMorgan Conference
Monday, January 11, 2016 - 1:02pm | 273Read More...Shares of Celgene Corporation (NASDAQ: CELG) were trading lower by nearly 5 percent late Monday morning following the company's presentation at the JPMorgan Healthcare Conference. Preliminary 2015 Results, 2016 Guidance Celgene said that it expects to earn $1.18 per share in the fourth quarter,...
-
HCA Holdings Raises Preliminary 2015 Results, Shares Spike Higher
Monday, January 11, 2016 - 10:13am | 154Read More...Shares of HCA Holdings Inc (NYSE: HCA) were trading higher by more than 5 percent early Monday morning after the company revised its prior adjusted EBITDA guidance higher. HCA Holdings said on Friday that it now expects its adjusted EBITDA for the full year fiscal 2015 to be exceed its prior...
-
Market Wrap For January 2: Markets Begin 2014 on Negative Note
Thursday, January 2, 2014 - 5:45pm | 1461Read More...Major indices saw plenty of red during the first trading session of 2014. There were no fundamental reasons for the Dow to suffer a triple digit point loss, along with the S&P 500 and Nasdaq indices ending the day lower. "People are taking profits and seeking bargains," according to Jim...
